QA: Arvinas INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001655759_2022_Arvinas_INC.pdf

Logs

Graph

Absolute values for 0001655759, Arvinas INC

  xvar xval
0 AssetsCurrent 1,552,500,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,700,000
3 remainder_Assets 16,400,000
4 LiabilitiesCurrent 261,700,000
5 LiabilitiesNoncurrent 538,200,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 177,959,203
9 ResearchAndDevelopmentExpense 540,620,731
10 remainder_Expenses 0
11 remainder_Revenues 38,271,379
12 remainder_NetIncome 4,770,262
13 remainder_ComprehensiveNetIncome 365,932
  yvar yval
0 Assets 1,581,600,000
1 Liabilities 799,900,000
2 Expenses 718,579,934
3 Revenues 38,271,379
4 StockholdersEquity 781,700,000
5 NetIncome -675,538,293
6 ComprehensiveNetIncome -675,355,327
7 BaseVar 1,571,743,754
8 EconomicCapitalRatiobeforeLimitedLiability 0.864
9 EconomicCapitalRatio 2.19

Edgar->Model Mapping

Feature Distribution

Change over Time